Cargando…
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes
OBJECTIVE: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. METHODS: Maternal circulating angiogenic facto...
Autores principales: | Cohen, Allison L., Wenger, Julia B., James-Todd, Tamarra, Lamparello, Brooke M., Halprin, Elizabeth, Serdy, Shanti, Fan, Shuling, Horowitz, Gary L., Lim, Kee-Hak, Rana, Sarosh, Takoudes, Tamara C., Wyckoff, Jennifer A., Thadhani, Ravi, Karumanchi, S. Ananth, Brown, Florence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare USA, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894714/ https://www.ncbi.nlm.nih.gov/pubmed/24354578 http://dx.doi.org/10.3109/10641955.2013.837175 |
Ejemplares similares
-
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
por: Rana, Sarosh, et al.
Publicado: (2022) -
Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia
por: March, Melissa I., et al.
Publicado: (2015) -
Time trends in pregnancy-related outcomes among women with type 1 diabetes mellitus, 2004–2017
por: Helman, Sarit, et al.
Publicado: (2020) -
Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia
por: Rana, Sarosh, et al.
Publicado: (2012) -
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia
por: Palomaki, Glenn E, et al.
Publicado: (2015)